C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

[1]  W. Koenig,et al.  C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Pepys,et al.  Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. , 1998, Clinical chemistry.

[3]  K. Kaikita,et al.  Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Berger.  Symptoms of chronic bronchitis and the risk of coronary disease , 1997 .

[5]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[6]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[8]  E. Bramucci,et al.  Tissue-factor antigen and activity in human coronary atherosclerotic plaques , 1997, The Lancet.

[9]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[10]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[11]  A. Döring,et al.  Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity. Results from a large population sample. , 1997, Circulation.

[12]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[13]  S. Thompson,et al.  Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. , 1996, Circulation.

[14]  P. Vokonas,et al.  Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.

[15]  J. Wright,et al.  Expression of C-reactive protein by alveolar macrophages. , 1996, Journal of immunology.

[16]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[17]  L. Kuller,et al.  ORIGINAL CONTRIBUTIONS Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study , 1996 .

[18]  I. Sartori.  Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris , 1996 .

[19]  C. Yutani,et al.  Immunohistochemical localization of C‐reactive protein‐binding sites in human atherosclerotic aortic lesions by a modified streptavidin‐biotin‐staining method , 1995, Pathology international.

[20]  F. Wolfe,et al.  The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[21]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[22]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[23]  C. Mold,et al.  Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. , 1994, Journal of immunology.

[24]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[25]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[26]  W. Koenig,et al.  Fibrinogen and Cardiovascular Risk , 1997, Vascular medicine.

[27]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[28]  M. Pepys,et al.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. , 1993, The Journal of clinical investigation.

[29]  Harry,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.

[30]  K. Beaman,et al.  Extrahepatic transcription of human C-reactive protein , 1991, The Journal of experimental medicine.

[31]  U. Keil,et al.  Case finding, data quality aspects and comparability of myocardial infarction registers: results of a south German register study. , 1991, Journal of clinical epidemiology.

[32]  J. Mehta,et al.  Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. , 1990, Journal of the American College of Cardiology.

[33]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[34]  K. Mattila.  Viral and bacterial infections in patients with acute myocardial infarction , 1989, Journal of internal medicine.

[35]  S Greenland,et al.  Modeling and variable selection in epidemiologic analysis. , 1989, American journal of public health.

[36]  S Böthig,et al.  WHO MONICA Project: objectives and design. , 1989, International journal of epidemiology.

[37]  L. Chambless,et al.  The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85. , 2009, Acta medica Scandinavica. Supplementum.

[38]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[39]  J. Kruskal,et al.  Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. , 1987, The New England journal of medicine.

[40]  J. Dormandy,et al.  Leukocytes and the risk of ischemic diseases. , 1987, JAMA.

[41]  M. Pepys,et al.  Immunohistochemical studies of c‐reactive protein and apolipoprotein b in inflammatory and arterial lesions , 1985, Journal of Pathology.

[42]  M. Pepys,et al.  C-reactive protein: binding to lipids and lipoproteins. , 1985, International review of experimental pathology.

[43]  D. Spodick,et al.  Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. , 1984, The American journal of cardiology.

[44]  H. Gewurz,et al.  EFFECTS OF C‐REACTIVE PROTEIN (CRP) ON PLATELET FUNCTION * , 1982, Annals of the New York Academy of Sciences.

[45]  J. Volanakis.  COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES * , 1982, Annals of the New York Academy of Sciences.

[46]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .

[47]  J. Volanakis,et al.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. , 1981, Journal of immunology.

[48]  G. Bray.  Definition, measurement, and classification of the syndromes of obesity. , 1978, International journal of obesity.

[49]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[50]  I. Knezevic,et al.  [Biological standardization]. , 1972, Harefuah.